ArticleImmunologic research2026
Inverse relationship between Epstein-Barr virus serostatus and anti-glutamic acid decarboxylase autoantibody levels.
Article in Immunologic research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Epstein-Barr virus (EBV) is suspected of being involved in the pathogenesis of several autoimmune diseases. However, its role in pancreatic islet autoimmunity remains to be determined. In the present study, the relationship between EBV serostatus and serum level of glutamic acid decarboxylase autoantibodies (GADA), a common marker of pancreatic islet autoimmunity, was investigated. Serum samples were collected from 158 individuals (aged 2–25 years) with GADA levels ≥ 0.7 U/mL and the EBV serostatus of each individual was determined. EBV seropositive (EBV+) individuals were defined as positive for both serum VCA IgG and EBNA IgG and EBV seronegative (EBV-) individuals were negative for these antibodies. Univariate and multivariate analyses were performed to investigate the association between EBV serostatus and GADA levels. EBV+ individuals tend to have lower GADA levels than EBV- individuals (p = 0.053). After adjustment for gender and age, mean GADA levels were significantly lower in EBV+ individuals than in EBV- individuals (9.34 U/mL versus 17.49 U/mL, respectively, p = 0.015). The lower GADA levels in EBV+ individuals suggest that there is an inverse relationship between pancreatic islet autoimmunity and EBV serostatus. Further studies are needed to investigate the role of EBV in pancreatic islet autoimmunity.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.